• No notifications yet.
  • Edit Profile
  • Settings
  • Invite Friends
  • Sign Out
logo image
  • logo image
  • More
Registered User? Login

Access to our event community is available to Professional, Speaker, Sponsor and VIP ticket holders only.  If you have not received the access code or would like to upgrade your ticket please get in touch with a member of the team at  ftlive@ft.com

Forgot Password?
Sign Up
loader image
New User? Sign Up

Access to our event community is available to Professional, Speaker, Sponsor and VIP ticket holders only.  If you have not received the access code or would like to upgrade your ticket please get in touch with a member of the team at  ftlive@ft.com

Forgot Password?
Login
loader image

    US Pharma and Biotech Summit

    May 5-6, 2021, 10:00-15:00 EDT
    Strategies for growth beyond the pandemic
    #FTUSPharma

    1000+
    Attendees
    30+
    Speakers
    800+
    Companies represented
    300m+
    Social Media Reach

    Global Clinical Research Partner
    Partner logo
    Lead Sponsor
    Partner logo
    Lead Sponsor
    Partner logo
    Lead Sponsor
    Partner logo
    Associate Sponsor
    Partner logo
    Associate Sponsor
    Partner logo

    The Financial Times US Pharma and Biotech Summit returns to examine the latest breakthroughs and trends in areas like drug development, market access, supply chains and health policy. 

    The coronavirus crisis spurred a tremendous wave of innovation and collaboration in life sciences, and nowhere more so than in the United States. But will renewed public trust in the pharma industry endure beyond the pandemic? How are product pipelines evolving? What are the prospects for US healthcare reform?

    Join leading FT journalists for two days of live panel discussions and keynote interviews with senior industry executives, thought leaders and investors. Sessions will explore the challenges and opportunities facing pharma and biotech companies as they help to shape the future of healthcare.   

    Central Themes

    Leading and learning

    Renewed public trust in the industry, the legacy of collaboration during the pandemic and priorities for investment

    Innovating and enabling

    New applications for advanced therapies, the future of clinical trials and the impact of digital transformation on workforces 

    Scaling up and ensuring access

    The evolution of supply chain management, prospects for US healthcare reform and the potential impact on market access

    World-class business leaders and speakers include

    speaker image
    AA
    Alisha Alaimo
    President
    Biogen U.S. Organization
    speaker image
    RB
    Robert Bradway
    Chairman and CEO
    Amgen
    speaker image
    ED
    Eloiza Domingo
    Executive Director and Global Head, Engagement, Diversity & Inclusion
    Astellas Pharma US
    speaker image
    MM
    Mike McDermott
    President
    Pfizer Global Supply
    speaker image
    CS
    Christi Shaw
    CEO
    Kite
    speaker image
    GY
    George Yancopoulos
    President and Chief Scientific Officer
    Regeneron

    Moderator

    speaker image
    HK
    Hannah Kuchler
    Pharmaceuticals Correspondent
    Financial Times

    "FT US Pharma and Biotech Summit is a must attend event, even in its virtual format presently required, since all of the leading companies and industry consultants send their top executives to speak on the future of our industry and they address both the difficult and the inspirational aspects of rapidly advancing technologies to deliver future healthcare innovation."
    Executive Chairman, KOP Therapeutics Corp

    Why Attend?

    Discuss

    The pharma industry's response to COVID-19 and whether the legacy of collaboration can continue

    Explore

    Applications for AI in R&D and debate the impact on company culture

    Examine

    New proposals for healthcare reform and query their potential to reshape the market

    Learn

    What it really means to be “patient-centric” and how it can support strategic goals

    Connect

    And build relationships with some of the biggest names in your industry

    Assess

    The potential of advanced therapies and consider challenges around market access 


    FT Live 2020: The Year in Review

    We would like to take this opportunity to look back and reflect on some incredible moments from last year. Thank you for being a part of the FTLive community and for your continued support.

    Other events

    Fast Forwarding the Future of Clinical Trials

    18 March 2021

    The Future of American Healthcare

    14 September 2021

    Global Pharmaceutical and Biotechnology Conference

    8-10 November 2021

    Contact Us

    Speaking Opportunities

    Ciaran Larkin
    ciaran.larkin@ft.com

    Sponsorship Opportunities

    Click here for more information

    Delegate Services

    Sean Hammond
    sean.hammond@ft.com

    © Financial Times Live

    FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice

                  

    LEGAL

    FT Live Website Terms of Use
    Slavery Statement & Policies
    Contact us



    FT Live Delegate Terms & Conditions
    Privacy policy
    Cookie policy